.:: TuttoCongressi ::.

Hai dimenticato la password? | Registrati

E-mail

Password

Resta Collegato

Cerca per parole nell'archivio:

In archivio:

N° Relazioni: 478
N° Accessi Relaz.: 168938

III° CONGRESSO ICAR 2011- Italian Conference on AIDS and Retroviruses.... -

Palazzo Congressi e Palazzo Affari (FI)
27/03/2011 - 29/03/2011

	Programma Evento
	Info

Mostra tutti | Mostra contenuti EasyRec

Lai A.
HIGH PROPORTION OF HIV-1 SUBTYPE F1 TRANSMISSION NETWORKS AMONG ITALIAN HETEROSEXUAL MALES ASSOCIATED WITH INTRODUCTION EVENTS FROM SOUTH AMERICA

Lazzarin A.
ARTEMIS: 192-WEEK EFFICACY AND SAFETY OF ONCEDAILY DARUNAVIR/RITONAVIR (DRV/R) VS LOPINAVIR/R (LPV/R) IN TREATMENT-NAÏVE HIV-1- INFECTED ADULTS

Levy J.
HIV/AIDS: THE IMPORTANCE OF INNATE IMMUNITY

Lichtner M.
TEST DAY IN THE ERA OF "SEEK, TEST AND TREAT" FOR HIV

Lisi L.
MODULATORY EFFECTS OF THE NOVEL CCR5 ANTAGONIST MARAVIROC ON MICROGLIAL PRO INFLAMMATORY ACTIVATION ELICITED BY GP120

Liuzzi G.
Females susceptibility to HIV infection

Lo Caputo S.
DID THE CHANGE OVER TIME IN HIV TREATMENT GUIDELINES AFFECT THE PROBABILITY OF ART INITIATION AT DIFFERENT LEVELS OF CURRENT CD4 COUNT? EVIDENCE FROM A COHORT OF HIV PATIENTS ENROLLED IN ITALY WHEN THEIR CD4 COUNT WAS >500 CELLS/MM3

Lopalco L.
NATURAL REGULATORS OF CCR5 INTERNALIZATION AND IMPLICATION FOR VACCINE AND THERAPEUTICS AGAINST HIV INFECTION